Compare OPAL & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAL | XTNT |
|---|---|---|
| Founded | 1998 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 61.7M |
| IPO Year | 2021 | 2009 |
| Metric | OPAL | XTNT |
|---|---|---|
| Price | $2.12 | $0.31 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $2.72 | $1.00 |
| AVG Volume (30 Days) | 165.0K | ★ 220.7K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 650.00 | 125.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $348,975,000.00 | $53,337,000.00 |
| Revenue This Year | $12.84 | N/A |
| Revenue Next Year | $9.11 | $9.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.34 | N/A |
| 52 Week Low | $1.65 | $0.27 |
| 52 Week High | $2.87 | $0.95 |
| Indicator | OPAL | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 42.17 | 30.11 |
| Support Level | $2.00 | $0.27 |
| Resistance Level | $2.44 | $0.47 |
| Average True Range (ATR) | 0.18 | 0.03 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 1.41 | 28.20 |
OPAL Fuels Inc is a fully integrated leader in the capture and conversion of biogas into low-carbon-intensity renewable natural gas and Renewable Power. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-decarbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas. The Company has three operating segments: RNG Fuel, Fuel Station Services, and Renewable Power.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.